EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations

Eleni Alexandri, Themistoklis Venianakis, Alexandra Primikyri, Georgios Papamokos iD, Ioannis P Gerothanassis iD

Molecules · 26.04.2023 · 28 (9) · 3724

DOI: 10.3390/molecules28093724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 26.04.2023. Verfasst von Eleni Alexandri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, Greece. Hauptthemen laut MEDLINE: Serum Albumin, Human, Eicosapentaenoic Acid. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Foundation for Research and Innovation (H.F.R.I.).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medium- and long-chain saturated and unsaturated free fatty acids (FFAs) are known to bind to human serum albumin (HSA), the main plasma carrier protein. Atomic-level structural data regarding the binding mode in Sudlow’s sites I (FA7) and II (FA4, FA3) of the polyunsaturated ω-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), however, are largely unknown. Herein, we report the combined use of saturation transfer difference (STD) and Interligand NOEs for Pharmacophore Mapping (INPHARMA) NMR techniques and molecular docking calculations to investigate the binding mode of DHA and EPA in Sudlow’s sites Ι and ΙΙ of HSA. The docking calculations and the significant number of interligand NOEs between DHA and EPA and the drugs warfarin and ibuprofen, which are stereotypical ligands for Sudlow’s sites I and II, respectively, were interpreted in terms of competitive binding modes and the presence of two orientations of DHA and EPA at the binding sites FA7 and FA4. The exceptional flexibility of the long-chain DHA and EPA and the formation of strongly folded structural motives are the key properties of HSA–PUFA complexes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serum Albumin, HumanEicosapentaenoic AcidHumansDocosahexaenoic AcidsMolecular Docking SimulationBinding SitesMagnetic Resonance SpectroscopyFatty Acids, Unsaturated

Stichwörter der Autor:innen

DHAEPAHSAINPHARMA NMRSTD NMRdocking calculations

Substanzen

Serum Albumin, HumanEicosapentaenoic AcidDocosahexaenoic AcidsFatty Acids, Unsaturated

Autor:innen und Institutionen

  • Section of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, Greece.

ORCID-Profile: Georgios Papamokos, Ioannis P Gerothanassis

Förderung

  • Hellenic Foundation for Research and Innovation (H.F.R.I.)

Zitieren

APA

Alexandri, E., Venianakis, T., Primikyri, A., Papamokos, G., & Gerothanassis, I. P. (2023). Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations. Molecules, 28(9), 3724. https://doi.org/10.3390/molecules28093724

Vancouver

Alexandri E, Venianakis T, Primikyri A, Papamokos G, Gerothanassis IP. Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations. Molecules. 2023;28(9):3724. doi:10.3390/molecules28093724

BibTeX
@article{Alexandri2023,
  author = {Alexandri, Eleni and Venianakis, Themistoklis and Primikyri, Alexandra and Papamokos, Georgios and Gerothanassis, Ioannis P},
  title = {Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {9},
  pages = {3724},
  doi = {10.3390/molecules28093724}
}
Kostenlos starten →